SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Renfan Xu, Anyu Tao, Shasha Zhang, Youbin Deng, Guangzhi Chen, Association Between Patatin-Like Phospholipase Domain Containing 3 Gene (PNPLA3) Polymorphisms and Nonalcoholic Fatty Liver Disease: A HuGE Review and Meta-Analysis, Scientific Reports, 2015, 5, 9284

    CrossRef

  2. 2
    Rotonya M. Carr, Jason Correnti, Insulin resistance in clinical and experimental alcoholic liver disease, Annals of the New York Academy of Sciences, 2015, 1345, 1
  3. 3
    Jérôme Boursier, Anna Mae Diehl, Patatin-like phospholipase domain-containing protein 3 and Liver Disease: Opportunities to Unravel Mechanisms Underlying Statistical Associations, Hepatology, 2015, 61, 1
  4. 4
    Long Zhang, Wei You, Hanze Zhang, Rui Peng, Qin Zhu, Aihua Yao, Xiangcheng Li, Yebin Zhou, Xuehao Wang, Liyong Pu, Jindao Wu, PNPLA3 polymorphisms (rs738409) and non-alcoholic fatty liver disease risk and related phenotypes: a meta-analysis, Journal of Gastroenterology and Hepatology, 2015, 30, 5
  5. 5
    Eriks Smagris, Soumik BasuRay, John Li, Yongcheng Huang, Ka-man V. Lai, Jesper Gromada, Jonathan C. Cohen, Helen H. Hobbs, Pnpla3I148M knockin mice accumulate PNPLA3 on lipid droplets and develop hepatic steatosis, Hepatology, 2015, 61, 1
  6. 6
    Winston Dunn, Maura O'Neil, Jie Zhao, Chuang Hong Wu, Benjamin Roberts, Shweta Chakraborty, Craig Sherman, Brandy Weaver, Ryan Taylor, Jody Olson, Mojtaba Olyaee, Richard Gilroy, Timothy Schmitt, Yu-Jui Yvonne Wan, Steven A. Weinman, Donor PNPLA3 rs738409 genotype affects fibrosis progression in liver transplantation for hepatitis C, Hepatology, 2014, 59, 2
  7. 7
    Kohichiroh Yasui, Takahisa Kawaguchi, Toshihide Shima, Hironori Mitsuyoshi, Kojiro Seki, Rei Sendo, Masayuki Mizuno, Yoshito Itoh, Fumihiko Matsuda, Takeshi Okanoue, Effect of PNPLA3 rs738409 variant (I148 M) on hepatic steatosis, necroinflammation, and fibrosis in Japanese patients with chronic hepatitis C, Journal of Gastroenterology, 2014,

    CrossRef

  8. 8
    Eylul Ece Islek, Ali Sazci, Mavi Deniz Ozel, Cem Aygun, Genetic Variants in thePNPLA3Gene Are Associated with Nonalcoholic Steatohepatitis, Genetic Testing and Molecular Biomarkers, 2014, 18, 7, 489

    CrossRef

  9. 9
    Christine C. McCann, Molly E. Viner, Shawn S. Donkin, H.M. White, Hepatic patatin-like phospholipase domain-containing protein 3 sequence, single nucleotide polymorphism presence, protein confirmation, and responsiveness to energy balance in dairy cows, Journal of Dairy Science, 2014, 97, 8, 5167

    CrossRef

  10. You have free access to this content10
    Masaya Sato, Naoya Kato, Ryosuke Tateishi, Ryosuke Muroyama, Norie Kowatari, Wenwen Li, Kaku Goto, Motoyuki Otsuka, Shuichiro Shiina, Haruhiko Yoshida, Masao Omata, Kazuhiko Koike, Impact of PNPLA3 polymorphisms on the development of hepatocellular carcinoma in patients with chronic hepatitis C virus infection, Hepatology Research, 2014, 44, 10
  11. 11
    Gianluigi Mazzoccoli, Manlio Vinciguerra, Jude Oben, Roberto Tarquini, Salvatore De Cosmo, Non-alcoholic fatty liver disease: the role of nuclear receptors and circadian rhythmicity, Liver International, 2014, 34, 8
  12. 12
    Nishika Sahini, Jürgen Borlak, Recent insights into the molecular pathophysiology of lipid droplet formation in hepatocytes, Progress in Lipid Research, 2014, 54, 86

    CrossRef

  13. 13
    Piero Pingitore, Carlo Pirazzi, Rosellina M. Mancina, Benedetta M. Motta, Cesare Indiveri, Arturo Pujia, Tiziana Montalcini, Kristina Hedfalk, Stefano Romeo, Recombinant PNPLA3 protein shows triglyceride hydrolase activity and its I148M mutation results in loss of function, Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2014, 1841, 4, 574

    CrossRef

  14. 14
    Vincent Zimmer, Frank Lammert, Role of genetics in diagnosis and therapy of acquired liver disease, Molecular Aspects of Medicine, 2014, 37, 15

    CrossRef

  15. 15
    Claudia D. Fuchs, Thierry Claudel, Michael Trauner, Role of metabolic lipases and lipolytic metabolites in the pathogenesis of NAFLD, Trends in Endocrinology & Metabolism, 2014, 25, 11, 576

    CrossRef

  16. 16
    D. G. Mashek, A. S. Greenberg, Serum TAG Analysis Differentiates Between Genetic and Obesity-Associated NAFLD, Diabetes, 2014, 63, 1, 42

    CrossRef

  17. 17
    Lei Hao, Kyoko Ito, Kuan-Hsun Huang, Sudathip Sae-tan, Joshua D. Lambert, A. Catharine Ross, Shifts in dietary carbohydrate-lipid exposure regulate expression of the non-alcoholic fatty liver disease-associated gene PNPLA3/adiponutrin in mouse liver and HepG2 human liver cells, Metabolism, 2014, 63, 10, 1352

    CrossRef

  18. 18
    Takuya Kitamoto, Aya Kitamoto, Masato Yoneda, Hideyuki Hyogo, Hidenori Ochi, Seiho Mizusawa, Takato Ueno, Kazuwa Nakao, Akihiro Sekine, Kazuaki Chayama, Atsushi Nakajima, Kikuko Hotta, Targeted next-generation sequencing and fine linkage disequilibrium mapping reveals association of PNPLA3 and PARVB with the severity of nonalcoholic fatty liver disease, Journal of Human Genetics, 2014, 59, 5, 241

    CrossRef

  19. 19
    George G. Schweitzer, Brian N. Finck, Targeting Hepatic Glycerolipid Synthesis and Turnover to Treat Fatty Liver Disease, Advances in Hepatology, 2014, 2014, 1

    CrossRef

  20. 20
    Ivana A. Stojkovic, Ulrika Ericson, Gull Rukh, Martin Riddestråle, Stefano Romeo, Marju Orho-Melander, The PNPLA3 Ile148Met interacts with overweight and dietary intakes on fasting triglyceride levels, Genes & Nutrition, 2014, 9, 2

    CrossRef

  21. 21
    Zheng Sun, Mitchell A. Lazar, Dissociating fatty liver and diabetes, Trends in Endocrinology & Metabolism, 2013, 24, 1, 4

    CrossRef

  22. 22
    Takuya Kitamoto, Aya Kitamoto, Masato Yoneda, Hideyuki Hyogo, Hidenori Ochi, Takahiro Nakamura, Hajime Teranishi, Seiho Mizusawa, Takato Ueno, Kazuaki Chayama, Atsushi Nakajima, Kazuwa Nakao, Akihiro Sekine, Kikuko Hotta, Genome-wide scan revealed that polymorphisms in the PNPLA3, SAMM50, and PARVB genes are associated with development and progression of nonalcoholic fatty liver disease in Japan, Human Genetics, 2013, 132, 7, 783

    CrossRef

  23. 23
    M.M.J. Guichelaar, S. Gawrieh, M. Olivier, K. Viker, A. Krishnan, S. Sanderson, M. Malinchoc, K.D. Watt, J.M. Swain, M. Sarr, M.R. Charlton, Interactions of allelic variance of PNPLA3 with nongenetic factors in predicting nonalcoholic steatohepatitis and nonhepatic complications of severe obesity, Obesity, 2013, 21, 9
  24. 24
    Luca Valenti, Paola Dongiovanni, Stefano Ginanni Corradini, Maria Antonella Burza, Stefano Romeo, PNPLA3 I148M variant and hepatocellular carcinoma: A common genetic variant for a rare disease, Digestive and Liver Disease, 2013, 45, 8, 619

    CrossRef

  25. 25
    Céline Dubuquoy, Anne-Françoise Burnol, Marthe Moldes, PNPLA3, a genetic marker of progressive liver disease, still hiding its metabolic function?, Clinics and Research in Hepatology and Gastroenterology, 2013, 37, 1, 30

    CrossRef

  26. 26
    Zeina Chamoun, Fabrizio Vacca, Robert G. Parton, Jean Gruenberg, PNPLA3/adiponutrin functions in lipid droplet formation, Biology of the Cell, 2013, 105, 5
  27. 27
    Naoki Kumashiro, Toru Yoshimura, Jennifer L. Cantley, Sachin K. Majumdar, Fitsum Guebre-Egziabher, Romy Kursawe, Daniel F. Vatner, Ioana Fat, Mario Kahn, Derek M. Erion, Xian-Man Zhang, Dongyan Zhang, Vara Prasad Manchem, Sanjay Bhanot, Glenn S. Gerhard, Kitt F. Petersen, Gary W. Cline, Varman T. Samuel, Gerald I. Shulman, Role of patatin-like phospholipase domain-containing 3 on lipid-induced hepatic steatosis and insulin resistance in rats, Hepatology, 2013, 57, 5
  28. 28
    Quentin M. Anstee, Christopher P. Day, The genetics of NAFLD, Nature Reviews Gastroenterology & Hepatology, 2013, 10, 11, 645

    CrossRef

  29. 29
    Manju Kumari, Gabriele Schoiswohl, Chandramohan Chitraju, Margret Paar, Irina Cornaciu, Ashraf Y. Rangrez, Nuttaporn Wongsiriroj, Harald M. Nagy, Pavlina T. Ivanova, Sarah A. Scott, Oskar Knittelfelder, Gerald N. Rechberger, Ruth Birner-Gruenberger, Sandra Eder, H. Alex Brown, Guenter Haemmerle, Monika Oberer, Achim Lass, Erin E. Kershaw, Robert Zimmermann, Rudolf Zechner, Adiponutrin Functions as a Nutritionally Regulated Lysophosphatidic Acid Acyltransferase, Cell Metabolism, 2012, 15, 5, 691

    CrossRef

  30. 30
    John Zhong Li, Yongcheng Huang, Ruchan Karaman, Pavlina T. Ivanova, H. Alex Brown, Thomas Roddy, Jose Castro-Perez, Jonathan C. Cohen, Helen H. Hobbs, Chronic overexpression of PNPLA3I148M in mouse liver causes hepatic steatosis, Journal of Clinical Investigation, 2012, 122, 11, 4130

    CrossRef

  31. 31
    Paula Oliver, Antoni Caimari, Rubén Díaz-Rúa, Andreu Palou, Cold exposure down-regulates adiponutrin/PNPLA3 mRNA expression and affects its nutritional regulation in adipose tissues of lean and obese Zucker rats, British Journal of Nutrition, 2012, 107, 09, 1283

    CrossRef

  32. 32
    Rudolf Zechner, Robert Zimmermann, Thomas O. Eichmann, Sepp D. Kohlwein, Guenter Haemmerle, Achim Lass, Frank Madeo, FAT SIGNALS - Lipases and Lipolysis in Lipid Metabolism and Signaling, Cell Metabolism, 2012, 15, 3, 279

    CrossRef

  33. 33
    Michael I. Goran, Ryan Walker, Hooman Allayee, Genetic-related and carbohydrate-related factors affecting liver fat accumulation, Current Opinion in Clinical Nutrition and Metabolic Care, 2012, 15, 4, 392

    CrossRef

  34. 34
    Tobias C. Walther, Robert V. Farese, Lipid Droplets and Cellular Lipid Metabolism, Annual Review of Biochemistry, 2012, 81, 1, 687

    CrossRef

  35. 35
    Ariel D. Quiroga, Richard Lehner, Liver triacylglycerol lipases, Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2012, 1821, 5, 762

    CrossRef

  36. 36
    Varman T. Samuel, Gerald I. Shulman, Mechanisms for Insulin Resistance: Common Threads and Missing Links, Cell, 2012, 148, 5, 852

    CrossRef

  37. 37
    Carlo Pirazzi, Martin Adiels, Maria Antonella Burza, Rosellina Margherita Mancina, Malin Levin, Marcus Ståhlman, Marja-Riitta Taskinen, Marju Orho-Melander, Jeanna Perman, Arturo Pujia, Linda Andersson, Cristina Maglio, Tiziana Montalcini, Olov Wiklund, Jan Borén, Stefano Romeo, Patatin-like phospholipase domain-containing 3 (PNPLA3) I148M (rs738409) affects hepatic VLDL secretion in humans and in vitro, Journal of Hepatology, 2012, 57, 6, 1276

    CrossRef

  38. 38
    Amnon Schlegel, Studying non-alcoholic fatty liver disease with zebrafish: a confluence of optics, genetics, and physiology, Cellular and Molecular Life Sciences, 2012, 69, 23, 3953

    CrossRef

  39. 39
    Hong-Min Ni, Jessica A. Williams, Hua Yang, Ying-Hong Shi, Jia Fan, Wen-Xing Ding, Targeting autophagy for the treatment of liver diseases, Pharmacological Research, 2012, 66, 6, 463

    CrossRef

  40. 40
    Silvia Sookoian, Carlos J. Pirola, The Genetic Epidemiology of Nonalcoholic Fatty Liver Disease, Clinics in Liver Disease, 2012, 16, 3, 467

    CrossRef

  41. 41
    Luca Valenti, Raffaela Rametta, Massimiliano Ruscica, Paola Dongiovanni, Liliana Steffani, Benedetta Motta, Elena Canavesi, Anna Fracanzani, Enrico Mozzi, Giancarlo Roviaro, Paolo Magni, Silvia Fargion, The i148m Pnpla3 polymorphism influences serum adiponectin in patients with fatty liver and healthy controls, BMC Gastroenterology, 2012, 12, 1, 111

    CrossRef

  42. 42
    Nicola Santoro, Clarence K. Zhang, Hongyu Zhao, Andrew J. Pakstis, Grace Kim, Romy Kursawe, Daniel J. Dykas, Allen E. Bale, Cosimo Giannini, Bridget Pierpont, Melissa M. Shaw, Leif Groop, Sonia Caprio, Variant in the glucokinase regulatory protein (GCKR) gene is associated with fatty liver in obese children and adolescents, Hepatology, 2012, 55, 3
  43. 43
    Bin Gao, Ramon Bataller, Alcoholic Liver Disease: Pathogenesis and New Therapeutic Targets, Gastroenterology, 2011, 141, 5, 1572

    CrossRef

  44. 44
    Lionel Hebbard, Jacob George, Animal models of nonalcoholic fatty liver disease, Nature Reviews Gastroenterology & Hepatology, 2011, 8, 1, 35

    CrossRef

  45. 45
    Eric Trépo, Denis Franchimont, Christophe Moreno, Association ofPNPLA3(rs738409 C>G) with liver damage in liver diseases: one step closer to personalized medicine?, Personalized Medicine, 2011, 8, 6, 595

    CrossRef

  46. 46
    Carmen Hurtado del Pozo, Gregorio Vesperinas-García, Miguel-Ángel Rubio, Ramón Corripio-Sánchez, Antonio J. Torres-García, Maria-Jesus Obregon, Rosa María Calvo, ChREBP expression in the liver, adipose tissue and differentiated preadipocytes in human obesity, Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2011, 1811, 12, 1194

    CrossRef

  47. 47
    Jiang Wei Wu, Shu Pei Wang, Fernando Alvarez, Stéphanie Casavant, Nicolas Gauthier, Lynda Abed, Krishnakant G. Soni, Gongshe Yang, Grant A. Mitchell, Deficiency of liver adipose triglyceride lipase in mice causes progressive hepatic steatosis, Hepatology, 2011, 54, 1
  48. 48
    Céline Dubuquoy, Céline Robichon, Françoise Lasnier, Clotilde Langlois, Isabelle Dugail, Fabienne Foufelle, Jean Girard, Anne-Françoise Burnol, Catherine Postic, Marthe Moldes, Distinct regulation of adiponutrin/PNPLA3 gene expression by the transcription factors ChREBP and SREBP1c in mouse and human hepatocytes, Journal of Hepatology, 2011, 55, 1, 145

    CrossRef

  49. 49
    J. C. Cohen, J. D. Horton, H. H. Hobbs, Human Fatty Liver Disease: Old Questions and New Insights, Science, 2011, 332, 6037, 1519

    CrossRef

  50. 50
    Sung Hee Choi, Henry N Ginsberg, Increased very low density lipoprotein (VLDL) secretion, hepatic steatosis, and insulin resistance, Trends in Endocrinology & Metabolism, 2011, 22, 9, 353

    CrossRef

  51. 51
    Achim Lass, Robert Zimmermann, Monika Oberer, Rudolf Zechner, Lipolysis – A highly regulated multi-enzyme complex mediates the catabolism of cellular fat stores, Progress in Lipid Research, 2011, 50, 1, 14

    CrossRef

  52. 52
    Rosalind A. Coleman, Douglas G. Mashek, Mammalian Triacylglycerol Metabolism: Synthesis, Lipolysis, and Signaling, Chemical Reviews, 2011, 111, 10, 6359

    CrossRef

  53. 53
    Aijun Qiao, Jichao Liang, Yaojun Ke, Chenghong Li, Ying Cui, Lian Shen, Huabing Zhang, Anfang Cui, Xiaojun Liu, Changzheng Liu, Yong Chen, Yi Zhu, Youfei Guan, Fude Fang, Yongsheng Chang, Mouse patatin-like phospholipase domain-containing 3 influences systemic lipid and glucose homeostasis, Hepatology, 2011, 54, 2
  54. 54
    Jonathan Z. Long, Benjamin F. Cravatt, The Metabolic Serine Hydrolases and Their Functions in Mammalian Physiology and Disease, Chemical Reviews, 2011, 111, 10, 6022

    CrossRef

  55. 55
    Herbert Tilg, Alexander R. Moschen, Evolution of inflammation in nonalcoholic fatty liver disease: The multiple parallel hits hypothesis, Hepatology, 2010, 52, 5
  56. 56
    Jeffrey D. Browning, Jonathan C. Cohen, Helen H. Hobbs, Patatin-like phospholipase domain-containing 3 and the pathogenesis and progression of pediatric nonalcoholic fatty liver disease, Hepatology, 2010, 52, 4
  57. 57
    Geoffrey C. Farrell, PNPLeAse get the fats right: Does lipogenesis or lipolysis cause NASH?, Hepatology, 2010, 52, 3
  58. 58
    Sharleen M. Rae-Whitcombe, Darnell Kennedy, Matt Voyles, Mary P. Thompson, Regulation of the promoter region of the human adiponutrin/PNPLA3 gene by glucose and insulin, Biochemical and Biophysical Research Communications, 2010, 402, 4, 767

    CrossRef

  59. 59
    Masafumi Ono, Nobuto Okamoto, Toshiji Saibara, The latest idea in NAFLD/NASH pathogenesis, Clinical Journal of Gastroenterology, 2010, 3, 6, 263

    CrossRef